Atrial Fibrillation Hub
Atrial fibrillation is the most common sustained cardiac arrhythmia, affecting over 6 million Americans. This module covers AFib recognition, classification, stroke risk stratification with CHA₂DS₂-VASc, rate vs. rhythm control concepts, and nursing assessment priorities.
Pre-Test — Atrial Fibrillation
~2 minAnswer a few quick questions before starting to measure your learning gain.
Overview
Atrial fibrillation is the most common sustained cardiac arrhythmia, affecting over 6 million Americans. This module covers AFib recognition, classification, stroke risk stratification with CHA₂DS₂-VASc, rate vs. rhythm control concepts, and nursing assessment priorities.
Learning Objectives
- 1.Recognize atrial fibrillation by its clinical and EKG features
- 2.Classify AFib: paroxysmal, persistent, long-standing persistent, and permanent ("chronic AF")
- 3.Apply the CHA₂DS₂-VASc score for stroke risk assessment
- 4.Understand the concepts of rate control vs. rhythm control
- 5.Know the nurse assessment priorities for a patient with new or symptomatic AFib
- 6.Educate patients on anticoagulation importance and fall risk
- 7.Communicate effectively with Spanish-speaking patients about palpitations and AFib
Choose Your View
Same topic, different depth. Jump to the view that matches your role.
Pathophysiology, differential, GDMT, and disposition decisions.
Scope: Clinical reasoning, diagnostics, and management. Not procedural or raw-imaging training.
Triage, escalation criteria, and patient education reinforcement.
Scope: Triage and workflow support. Does not replace institutional protocols or provider direction.
Rooming, vitals, red flags, and what to report immediately.
Scope: Safe data collection and escalation. Not independent triage or clinical decision-making.
Start with the lesson and cheat sheet, then test yourself with the quiz.
Scope: Introductory learning, to be used under supervision.
APP Lesson: Atrial Fibrillation Foundations
What is Atrial Fibrillation?
- ›Atrial fibrillation (AFib) is a supraventricular arrhythmia characterized by chaotic, disorganized atrial electrical activity and an irregularly irregular ventricular response. The atria fire at 400–600 impulses per minute but only a fraction reach the ventricles through the AV node, resulting in an irregular pulse.
- ›On EKG, AFib appears as: absence of discrete P waves (replaced by irregular fibrillatory baseline), irregularly irregular R-R intervals, and narrow QRS complexes unless aberrant conduction or bundle branch block is present.
- ›AFib is associated with significantly increased risk of stroke (5x higher than the general population), heart failure, and reduced quality of life. Recognition and appropriate management are critical for all cardiology team members.
Classification of AFib
- ›Paroxysmal AFib: Episodes terminate spontaneously within 7 days. Patient may or may not be symptomatic. These patients still carry stroke risk and need CHA₂DS₂-VASc scoring.
- ›Persistent AFib: Episode lasts longer than 7 days, or requires cardioversion (electrical or pharmacological) to restore sinus rhythm.
- ›Long-standing persistent AFib: Continuous AFib lasting more than 12 months in a patient for whom a rhythm-control strategy is still being pursued.
- ›Permanent AFib ("chronic AF"): A joint decision between patient and clinician to accept ongoing AFib and no longer pursue rhythm control — care shifts to rate control and stroke prevention. This is a treatment strategy, not an irreversible state.
- ›New-onset AFib: First detected episode; may be of uncertain duration. Anticoagulation and rate/rhythm decisions are particularly nuanced when duration is unknown.
CHA₂DS₂-VASc Score and Stroke Risk
- ›The CHA₂DS₂-VASc score estimates stroke risk in non-valvular AFib and guides anticoagulation decisions. Each letter represents a risk factor.
- ›C — Congestive heart failure (1 point). H — Hypertension (1 point). A₂ — Age ≥75 (2 points). D — Diabetes mellitus (1 point). S₂ — Stroke/TIA/thromboembolism history (2 points). V — Vascular disease (PAD, prior MI, aortic plaque) (1 point). A — Age 65–74 (1 point). Sc — Sex category: female (1 point).
- ›Score 0 in males or 1 in females: Low risk — anticoagulation not generally recommended. Score 1 in males: Consider OAC. Score ≥2 in males or ≥3 in females: OAC recommended (unless significant bleeding risk outweighs benefit).
- ›Direct oral anticoagulants (DOACs — apixaban, rivaroxaban, dabigatran, edoxaban) are preferred over warfarin for most patients with non-valvular AFib. They have superior efficacy and safety profiles with fewer drug and dietary interactions.
- ›HAS-BLED score estimates bleeding risk on anticoagulation. A high score does not automatically mean OAC is contraindicated — rather, modifiable risk factors should be corrected and the benefit-risk balance weighed carefully.
- ›Apply CHA₂DS₂-VASc across ALL AFib patterns (paroxysmal, persistent, long-standing persistent, permanent) — the decision is risk-based, not pattern-based. Non-paroxysmal AFib may carry modestly higher thromboembolic risk in some studies, but most patients with persistent or permanent AFib already fall in the intermediate-to-high zones where OAC is reasonable-to-recommended. Paroxysmal AFib is NOT "low-risk" enough to withhold indicated anticoagulation, and HAS-BLED is for addressing modifiable bleeding risk — not for withholding indicated OAC.
- ›Left atrial appendage occlusion (LAAO, e.g., Watchman): a reasonable alternative (Class 2a in the 2023 guideline) for patients with a long-term contraindication to oral anticoagulation but a moderate-to-high stroke risk. Note: DOACs are preferred over warfarin EXCEPT in mechanical heart valves or moderate-to-severe (rheumatic) mitral stenosis, where warfarin is required.
Rate Control vs. Rhythm Control
- ›Rate control focuses on slowing the ventricular response to AFib (typically target HR <110 bpm at rest) without necessarily restoring sinus rhythm. It is often the initial approach for older patients, those with permanent AFib, and those with minimal symptoms.
- ›Common rate control agents include beta-blockers (metoprolol, atenolol, carvedilol) and non-dihydropyridine calcium channel blockers (diltiazem, verapamil). Digoxin can supplement but is generally not first-line.
- ›Rhythm control focuses on restoring and maintaining sinus rhythm. Strategies include pharmacological cardioversion (antiarrhythmic drugs) or electrical cardioversion (DC cardioversion), often followed by antiarrhythmic maintenance therapy or catheter ablation.
- ›Catheter ablation (pulmonary vein isolation): the 2023 ACC/AHA/ACCP/HRS guideline makes ablation a Class 1, first-line rhythm-control option for selected symptomatic paroxysmal AFib (especially younger patients with few comorbidities) and a Class 1 recommendation in AFib with HFrEF, where it improves survival and reduces HF hospitalization (EAST-AFNET 4, CASTLE-AF). The guideline also emphasizes early rhythm control and aggressive risk-factor modification (weight loss, BP, sleep apnea, alcohol reduction).
- ›Important caveat: rhythm control does NOT eliminate stroke risk in most patients. Anticoagulation is still required based on CHA₂DS₂-VASc score regardless of rhythm control strategy, because paroxysmal episodes may be silent.
Anticoagulation Education for Patients
- ›Patient education about anticoagulation is one of the most important nursing and APP responsibilities in AFib management. Many patients stop their blood thinners because they feel well, don't understand the purpose, or are concerned about bleeding.
- ›Key messages: AFib increases stroke risk 5 times. The blood thinner prevents clots from forming in the heart and traveling to the brain. Most people need to take this medicine every day, even when they feel fine and even when they're back in normal rhythm.
- ›Fall risk: Patients on anticoagulation have higher bleeding risk from falls. However, for most AFib patients, the stroke risk from stopping anticoagulation outweighs fall-related bleeding risk. The decision is individualized — consult with the provider rather than stopping independently.
- ›Missed doses: For DOACs, patients should take the missed dose as soon as they remember on the same day — not double-dose the next day.
Red Flags / When to Escalate
- ›Rapid ventricular response with hemodynamic instability (hypotension, chest pain, syncope, altered mental status) — this is an emergency
- ›New onset AFib with heart rate >150 bpm and symptoms
- ›Suspected stroke or TIA symptoms in patient with AFib — immediate 911
- ›Signs of heart failure decompensation driven by uncontrolled AFib
- ›Pre-excitation on EKG with rapid AFib (WPW) — extremely dangerous, do not give AV nodal blockers
- ›Patient reports stopping anticoagulation without provider knowledge
- ›New significant bleeding in an anticoagulated patient
Clinical Cheat Sheet
EKG Features of AFib
- •No distinct P waves (fibrillatory baseline)
- •Irregularly irregular R-R intervals
- •Narrow QRS (unless aberrancy or BBB)
- •Variable ventricular rate — can be slow, normal, or rapid
CHA₂DS₂-VASc Score
- •C — CHF: 1 point
- •H — Hypertension: 1 point
- •A₂ — Age ≥75: 2 points
- •D — Diabetes: 1 point
- •S₂ — Stroke/TIA history: 2 points
- •V — Vascular disease: 1 point
- •A — Age 65–74: 1 point
- •Sc — Sex female: 1 point
- •≥2 (male) or ≥3 (female): OAC recommended
Ask
- •When did palpitations / symptoms start?
- •Lightheadedness or near-syncope?
- •Chest pain or pressure?
- •Shortness of breath?
- •Prior history of AFib?
- •On anticoagulation? Taking it?
- •Recent missed doses?
- •Any alcohol use or stimulants?
- •Thyroid history?
- •Recent illness or stress?
Escalate Immediately
- •HR >150 with hemodynamic instability
- •Stroke/TIA symptoms — call 911
- •Syncope or near-syncope
- •Signs of heart failure
- •Pre-excitation pattern on EKG with rapid AFib (WPW)
- •New significant bleeding on anticoagulation
Nurse Assessment Checklist
Systematic assessment for patients with known or suspected AFib, or with palpitations/irregular pulse.
Vital Signs and Pulse Assessment
- Heart rate — is it irregular? Count for full 60 seconds
- Blood pressure
- Oxygen saturation
- Respiratory rate
- Temperature (fever can trigger or worsen AFib)
- Weight (compare to baseline for fluid status)
Symptom Assessment
- Palpitations — when did they start?
- Lightheadedness or dizziness
- Syncope or near-syncope
- Shortness of breath at rest or with activity
- Chest pain or pressure
- Fatigue or reduced exercise tolerance
- How symptomatic is the patient on a scale of 1–4?
Anticoagulation Status
- Is the patient on an anticoagulant?
- Which medication and dose?
- When was the last dose taken?
- Any missed doses recently?
- Any new bleeding (bruising, blood in urine/stool, nosebleeds)?
- Any recent falls or fall risk concerns?
- Recent INR if on warfarin
Medical History to Gather
- Prior diagnosis of AFib? When?
- Paroxysmal, persistent, or permanent?
- Prior cardioversion or ablation?
- History of stroke or TIA?
- Heart failure, hypertension, or diabetes?
- Thyroid disease?
- Recent alcohol use, stress, infection, or surgery?
Escalate Immediately If
- HR consistently >150 bpm with any hemodynamic concern
- Patient reports stroke-like symptoms (facial droop, arm weakness, slurred speech)
- Syncope or near-syncope
- Chest pain suggesting ACS
- Signs of acute heart failure
- Patient appears unwell, pale, diaphoretic
Patient Education Handout
What is Atrial Fibrillation?
- Atrial fibrillation (AFib) is an irregular heartbeat. The upper chambers of your heart (atria) beat in a fast, chaotic way instead of a steady rhythm.
- AFib is very common. Many people have it. With the right care, most people with AFib live active, normal lives.
- AFib increases the risk of stroke. This is why your doctor may prescribe a blood thinner medicine.
Symptoms of AFib
- Some people feel their heart fluttering, racing, or flopping.
- Some feel tired, short of breath, or dizzy.
- Some people have no symptoms at all.
- AFib can come and go (paroxysmal) or stay all the time.
Why Blood Thinners Are Important
- When your heart is in AFib, blood can pool in the heart and form a clot.
- If that clot travels to the brain, it causes a stroke.
- Blood thinners help prevent clots from forming.
- Take your blood thinner every day as prescribed — even when you feel normal.
- Do NOT stop your blood thinner without talking to your doctor first.
Fall Safety with Blood Thinners
- Blood thinners make you bleed more easily if you are cut or injured.
- Be careful to prevent falls: remove rugs, use non-slip mats, hold handrails.
- If you fall and hit your head, go to the ER — even if you feel okay.
- Tell your doctor if you are concerned about falling.
What to Watch For
- Call 911 immediately if you have sudden numbness or weakness on one side, sudden trouble speaking, or sudden severe headache — these are stroke warning signs.
- Call your clinic if: your heart is racing and you feel faint, you are very short of breath, you have chest pain, or your symptoms are getting worse.
- Bring your medication bottles to all appointments.
Things That Can Trigger AFib
- Too much alcohol or caffeine
- Illness, fever, or infection
- Stress or lack of sleep
- Thyroid problems
- Missed medications
- Let your doctor know if your symptoms seem to happen at certain times.
This handout is for education only and does not replace medical advice from your healthcare team.
Spanish / Communication Phrases
Are you feeling your heart racing or fluttering?
¿Siente que el corazón le palpita o late rápido?
When did the palpitations start?
¿Cuándo empezaron las palpitaciones?
Are you dizzy or lightheaded?
¿Tiene mareo o se siente mareado?
Are you taking your blood thinner?
¿Está tomando su medicina para la sangre?
Have you missed any doses?
¿Se le ha olvidado tomar alguna dosis?
Are you having any bleeding — nosebleeds, blood in urine?
¿Tiene algún sangrado — como sangre por la nariz o en la orina?
Do you have shortness of breath?
¿Le falta el aire?
We need to do a heart tracing test.
Necesitamos hacerle un electrocardiograma.
Do not stop your blood thinner without talking to your doctor.
No deje de tomar su medicina sin hablar con su médico.
We need an interpreter to explain your treatment plan.
Necesitamos un intérprete para explicar su plan de tratamiento.
Sim Patient Case
Patient
[EN] 72-year-old Spanish-speaking female with hypertension and type 2 diabetes. No prior AFib diagnosis. [ES] Mujer de 72 años, hispanohablante, con hipertensión y diabetes tipo 2. Sin diagnóstico previo de fibrilación auricular.
Chief Complaint
[EN] "My heart is racing and fluttering. I feel dizzy and tired. It started this morning." [ES] "Mi corazón está acelerado y agitado. Me siento mareada y cansada. Empezó esta mañana."
Vitals
148/88 mmHg
118 bpm — irregularly irregular
18 breaths/min
96%
98.2°F
Stable from prior visit
Goal
[EN] Recognize new-onset AFib, calculate CHA₂DS₂-VASc, understand rate vs. rhythm considerations, and assess anticoagulation need. [ES] Reconozca la fibrilación auricular de nueva aparición, calcule la puntuación CHA₂DS₂-VASc, comprenda las consideraciones de control de frecuencia versus ritmo y evalúe la necesidad de anticoagulación.
Knowledge Check Quiz
Stay sharp — get new modules in your inbox
New clinical topics, tools, and bedside cheat sheets for the cardiology care team. No spam, unsubscribe anytime.